1,755 filings
Page 25 of 88
6-K
osu8kg9oeg0
25 Sep 15
Teva Reinforces Leadership Position in Respiratory with Acquisition of Gecko Health Innovations
12:00am
6-K
c6w1jld8espp1
10 Sep 15
Live Filing
12:00am
6-K
fkdpgme3lteye292g5a
10 Sep 15
Teva Pharmaceuticals and IBM Partner to Build Global e-Health Solutions on the IBM Watson Health Cloud
12:00am
6-K
1b1rbeqxh1nt06dn18m
8 Sep 15
Live Filing
12:00am
S-8
le1z2n
3 Sep 15
Registration of securities for employees
12:00am
6-K
pvcpmdm4zd
3 Sep 15
Live Filing
12:00am
6-K
hy70rof8h5bq3a
1 Sep 15
Live Filing
12:00am
6-K
jwpf 32it
25 Aug 15
Live Filing
12:00am
6-K
cbzi3p81k kdfvmi
12 Aug 15
Teva Announces FDA Acceptance of NDA for SD-809 for Treatment in Huntington Disease
12:00am
6-K
ixj0w mbm
3 Aug 15
Teva gains exclusive rights to Immuneering’s cutting-edge analytics to advance treatments for diseases of the CNS
12:00am
6-K
qvh3slvuuory
3 Aug 15
Current report (foreign)
12:00am
6-K
7e8kpst cr
31 Jul 15
Teva Secures $33.75 Billion Financing Commitment
12:00am
6-K
v03pol5e2ifjzs
30 Jul 15
Teva Reports Strong Second Quarter 2015 Results and Raises Guidance for Full-Year 2015
12:00am
6-K
10iu0peyiq5d8 7x
30 Jul 15
Current report (foreign)
12:00am
6-K
hf4yvnns2 xmvmd
30 Jul 15
Current report (foreign)
12:00am
6-K
o52e12p3 i1w
28 Jul 15
Current report (foreign)
12:00am
6-K
aae5o9
28 Jul 15
Teva Announces European Medicines Agency (EMA) Confirms Successful Validation of Reslizumab Marketing Authorization Application
12:00am
6-K
lg1bwyy7u5xa74c
27 Jul 15
Teva to Acquire Allergan Generics for $40.5 Billion
12:00am
6-K
pv6ddzq7
21 Jul 15
Live Filing
12:00am
6-K
p8rya3z 4l
8 Jul 15
Teva First to Receive Approval and Launch Generic Axert®tablets In the United States
12:00am